Belcheva MM[au] - Search Results

Year	Number of Results
1991	3
1992	3
1993	2
1994	5
1995	2
1996	2
1997	1
1998	4
1999	1
2000	3
2001	1
2002	2
2003	1
2004	1
2005	2
2006	2
2008	1
2009	2
2010	2
2013	1
2014	1
2023	0

1

Diversity of G protein-coupled receptor signaling pathways to ERK/MAP kinase.

Belcheva MM, Coscia CJ. Belcheva MM, et al. Neurosignals. 2002 Jan-Feb;11(1):34-44. doi: 10.1159/000057320. Neurosignals. 2002. PMID: 11943881 Free PMC article. Review.

2

Kappa-opioid receptor binding varies inversely with tumor grade in human gliomas.

Pan EC, Bohn LM, Belcheva MM, Thomas GE, Manepalli AN, Mamone JY, Johnson FE, Coscia CJ. Pan EC, et al. Among authors: belcheva mm. Cancer. 1998 Dec 15;83(12):2561-6. doi: 10.1002/(sici)1097-0142(19981215)83:12<2561::aid-cncr23>3.0.co;2-h. Cancer. 1998. PMID: 9874464

3

Mu and kappa opioids modulate mouse embryonic stem cell-derived neural progenitor differentiation via MAP kinases.

Hahn JW, Jagwani S, Kim E, Rendell VR, He J, Ezerskiy LA, Wesselschmidt R, Coscia CJ, Belcheva MM. Hahn JW, et al. Among authors: belcheva mm. J Neurochem. 2010 Mar;112(6):1431-41. doi: 10.1111/j.1471-4159.2009.06479.x. Epub 2009 Nov 6. J Neurochem. 2010. PMID: 19895666 Free PMC article.

4

Acute and chronic mu opioids differentially regulate thrombospondins 1 and 2 isoforms in astrocytes.

Phamduong E, Rathore MK, Crews NR, D'Angelo AS, Leinweber AL, Kappera P, Krenning TM, Rendell VR, Belcheva MM, Coscia CJ. Phamduong E, et al. Among authors: belcheva mm. ACS Chem Neurosci. 2014 Feb 19;5(2):106-14. doi: 10.1021/cn400172n. Epub 2013 Dec 5. ACS Chem Neurosci. 2014. PMID: 24304333 Free PMC article.

5

Mu- and kappa-opioids induce the differentiation of embryonic stem cells to neural progenitors.

Kim E, Clark AL, Kiss A, Hahn JW, Wesselschmidt R, Coscia CJ, Belcheva MM. Kim E, et al. Among authors: belcheva mm. J Biol Chem. 2006 Nov 3;281(44):33749-60. doi: 10.1074/jbc.M603862200. Epub 2006 Sep 1. J Biol Chem. 2006. PMID: 16954126 Free PMC article.

6

Kappa opioids promote the proliferation of astrocytes via Gbetagamma and beta-arrestin 2-dependent MAPK-mediated pathways.

McLennan GP, Kiss A, Miyatake M, Belcheva MM, Chambers KT, Pozek JJ, Mohabbat Y, Moyer RA, Bohn LM, Coscia CJ. McLennan GP, et al. Among authors: belcheva mm. J Neurochem. 2008 Dec;107(6):1753-65. doi: 10.1111/j.1471-4159.2008.05745.x. Epub 2008 Nov 10. J Neurochem. 2008. PMID: 19014370 Free PMC article.

7

Buprenorphine differentially alters opioid receptor adaptation in rat brain regions.

Belcheva MM, Ho MT, Ignatova EG, Jefcoat LB, Barg J, Vogel Z, McHale RJ, Johnson FE, Coscia CJ. Belcheva MM, et al. J Pharmacol Exp Ther. 1996 Jun;277(3):1322-7. J Pharmacol Exp Ther. 1996. PMID: 8667193 Free PMC article.

8

A monoclonal anti-idiotypic antibody to mu and delta opioid receptors.

Coscia CJ, Szücs M, Barg J, Belcheva MM, Bem WT, Khoobehi K, Donnigan TA, Juszczak R, McHale RJ, Hanley MR, et al. Coscia CJ, et al. Among authors: belcheva mm. Brain Res Mol Brain Res. 1991 Mar;9(4):299-306. doi: 10.1016/0169-328x(91)90076-a. Brain Res Mol Brain Res. 1991. PMID: 1645433

9

Evidence for kappa- and mu-opioid receptor expression in C6 glioma cells.

Bohn LM, Belcheva MM, Coscia CJ. Bohn LM, et al. Among authors: belcheva mm. J Neurochem. 1998 May;70(5):1819-25. doi: 10.1046/j.1471-4159.1998.70051819.x. J Neurochem. 1998. PMID: 9572265 Free PMC article.

10

Brain opioid receptor adaptation and expression after prenatal exposure to buprenorphine.

Belcheva MM, Bohn LM, Ho MT, Johnson FE, Yanai J, Barron S, Coscia CJ. Belcheva MM, et al. Brain Res Dev Brain Res. 1998 Nov 1;111(1):35-42. doi: 10.1016/s0165-3806(98)00117-5. Brain Res Dev Brain Res. 1998. PMID: 9804882

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results